# Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-treatment-in-adults-with-refractory-minimal-change-disease-or-focal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hong Ren,Li Lin,Pingyan Shen,Xiao Li,Jingyuan Xie,Xiaoxia Pan,Wen Zhang,Nan Chen |
| Citations | 27 |
| DOI | 10.18632/oncotarget.21833 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.oncotarget.com/article/21833/pdf/ |
| OpenAlex ID | https://openalex.org/W2762055363 |
| PMID | 29212162 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Hong Ren](https://scholariq.org/researchers/hong-ren/)
- [Jingyuan Xie](https://scholariq.org/researchers/jingyuan-xie/)
- [Wen Zhang](https://scholariq.org/researchers/wen-zhang/)
- [Xiao Li](https://scholariq.org/researchers/xiao-li/)
- [Xiaoxia Pan](https://scholariq.org/researchers/xiaoxia-pan/)

## Paper funders

- [National Natural Science Foundation of China](https://scholariq.org/funders/national-natural-science-foundation-of-china/)
- [National Key Research and Development Program of China](https://scholariq.org/funders/national-key-research-and-development-program-of-china/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.